Scott Brakenridge, MD, professor of surgery in the Division of Trauma, Burn & Critical Care Surgery at Seattle-based Harborview Medical Center, has been appointed chair of the National Institutes of Health’s Maximizing Investigators’ Research Award Study Section.
Dr. Brakenridge will serve as chair from 2026 to 2028. The MIRA study section oversees scientific peer review of grant applications tied to one of NIH’s premier investigator-initiated research programs, evaluating proposals for rigor and scientific merit, according to a July 21 news release.
The role places Dr. Brakenridge among a small group of surgeon-scientists tasked with leading federal peer review for biomedical research funding. Study section chairs help determine which research proposals advance for NIH funding consideration.
Harborview Medical Center, part of UW Medicine, is the only level 1 adult and pediatric trauma and burn center in Washington state.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
